Hematology
A section of Journal of Clinical Medicine (ISSN 2077-0383).
Section Information
Hematology is the subspecialty of internal medicine that deals with diseases of the blood, bone marrow, and lymphatic system. The main topics managed by hematologists include anemias, hematological malignancies (leukemias and lymphomas multiple myeloma) and other clonal disorders, transplantation of hematopoietic stem cells including cellular therapy, congenital and acquired diseases of hemostasis, coagulation, thrombotic diseases, blood banking, and transfusion medicine. The journal aims to provide information and updates on all aspects of clinical and laboratory hematology, from clinical trials to real-world clinical practice.
Subject areas:
- oncological and non-oncological hematological diseaseshematopoiesis
- disorders of leukocytes
- erythrocytes and platelets
- iron metabolism
- hemostaseology
- thrombotic and bleeding disorders
- immunology
- transfusion medicine
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Diagnosis and Clinical Management in Hematologic Oncology (Deadline: 20 August 2026)
- Bleeding and Thrombotic Complications in Patients with Premalignant Hematologic Conditions: Diagnostic and Therapeutic Challenges (Deadline: 20 August 2026)
- Clinical Updates in Stem Cell Transplants (Deadline: 28 August 2026)
- Clinical Advances in Prevention and Treatment of Cancer-Associated Venous Thromboembolism (Deadline: 20 September 2026)
- Myeloid-Derived Suppressor and Innate Immune Cells in Hematologic, Malignant and Chronic Diseases (Deadline: 25 September 2026)
- Idiopathic Thrombocytopenic Purpura (ITP) and Thrombotic Thrombocytopenic Purpura (TTP): Pathophysiology, Clinical Practice and Future Developments (Deadline: 25 September 2026)
- Updates and Advances in Aplastic Anemia and Other Bone Marrow Failures (Deadline: 30 September 2026)
- Acute Myeloid Leukemia: Latest Advances in Diagnostics, Therapeutic Strategies and Clinical Management: 2nd Edition (Deadline: 20 October 2026)
- Clinical Blood Transfusion: History, Development, Need, Demand and Use (Deadline: 20 October 2026)
- Hematologic Malignancies: Treatment Strategies and Future Challenges: 2nd Edition (Deadline: 25 October 2026)
- Advancing the Clinical Management of Myeloproliferative Neoplasms (MPNs) (Deadline: 18 November 2026)
- Thromboembolic Disease and Antithrombotic Therapy: 2nd Edition (Deadline: 20 November 2026)
- Hematopoietic Stem Cell Transplantation: Current Research and New Perspectives (Deadline: 20 November 2026)
- Bleeding Disorders and Hemophilia: Clinical Advances and Treatment (Deadline: 25 November 2026)
- Hematological Neoplasms: Diagnosis, Treatment, and Management in the Department of Veterans Affairs (Deadline: 25 November 2026)
- Clinical Management and Advances in Hereditary Hemorrhagic Telangiectasia (Deadline: 20 December 2026)
- New Developments in Hematopoietic Stem Cell Transplantation in Clinical Practice (Deadline: 25 December 2026)
- Anemia: Clinical Updates in Diagnosis, Management, and Treatment (Deadline: 31 December 2026)
- Deep Vein Thrombosis and Pulmonary Embolism: Clinical Treatment and Management—Second Edition (Deadline: 20 January 2027)
- Advancements in the Treatment of Myeloproliferative Neoplasms and Myelodysplastic Syndromes (Deadline: 20 January 2027)
- Clinical Updates in Transfusion Medicine and Patient Blood Management (Deadline: 20 January 2027)
- Acute Myeloid Leukemia: From Molecular Complexity to Precision Medicine (Deadline: 20 January 2027)
- Focus on Multiple Myeloma: Diagnosis, Therapy and Clinical Outcome (Deadline: 20 February 2027)
- Hemophilia: Current Trends and Future Directions: 2nd Edition (Deadline: 20 March 2027)
- Bidirectional Interplay Between Hematological Malignancies and Comorbidities (Deadline: 20 April 2027)
